Inti email:
Enseval cek: Alfresa sudah pernah bertemu dg Kalbe Farma (principalnya
Enseval).
Namun terhambat kalau mau Distribusi Ethical di Indo harus punya Pabrik
Farmasi disini.
Dg Enseval belum pernah bertemu.
Enseval Business Development Division akan cek lagi possibilitynya dan file
terakhir Meeting dg Kalbe seperti apa.
Direktur yg dulu urus, sudah resign.
Jadi sekarang di Enseval New Director.
Dia akan kabari lagi minggu depan sekitar hari Rabu. Tq
Sy going cek juga dg company pharmacy lainnya. Apakah bisa.
Herewith, we would like to inform you that:
We have contacted PT. Enseval about the possibility of cooperation with
Alfresa Co, Ltd.
According to the information we received from the Enseval Director, that
PT. Kalbe Farma as the principal of Enseval, has held a meeting with
Alfresa Co, Ltd.
At the meeting also noted that there are obstacles to the licensing of
foreign pharmaceutical company as a drug manufacturer of prescription
drugs, if you want to distributing drugs in Indonesia, the company must
have a permit and has a factory in Indonesia.
Because the new Enseval Director himself did not join the meeting (the old
director who has this information already retired). The new director will
coordinate with Business Development Division of Enseval to seek more
detailed information about the meeting and see again the possibility of
cooperation with Alfresa Co, Ltd.
As soon as we got the information from him, we will contact you again.
Inti email:
Enseval cek: Alfresa sudah pernah bertemu dg Kalbe Farma (principalnya
Enseval).
Namun terhambat kalau mau Distribusi Ethical di Indo harus punya Pabrik
Farmasi disini.
Dg Enseval belum pernah bertemu.
Enseval Business Development Division akan cek lagi possibilitynya dan file
terakhir Meeting dg Kalbe seperti apa.
Direktur yg dulu urus, sudah resign.
Jadi sekarang di Enseval New Director.
Dia akan kabari lagi minggu depan sekitar hari Rabu. Tq
Sy going cek juga dg company pharmacy lainnya. Apakah bisa.
Herewith, we would like to inform you that:
We have contacted PT. Enseval about the possibility of cooperation with
Alfresa Co, Ltd.
According to the information we received from the Enseval Director, that
PT. Kalbe Farma as the principal of Enseval, has held a meeting with
Alfresa Co, Ltd.
At the meeting also noted that there are obstacles to the licensing of
foreign pharmaceutical company as a drug manufacturer of prescription
drugs, if you want to distributing drugs in Indonesia, the company must
have a permit and has a factory in Indonesia.
Because the new Enseval Director himself did not join the meeting (the old
director who has this information already retired). The new director will
coordinate with Business Development Division of Enseval to seek more
detailed information about the meeting and see again the possibility of
cooperation with Alfresa Co, Ltd.
As soon as we got the information from him, we will contact you again.
翻訳されて、しばらくお待ちください..
